HBV Vaccination: Birth Dose Safe, May Reduce HIV Coinfection
Systematic review confirms hepatitis B birth dose is safe and effective; separate study finds childhood vaccination linked to significantly lower HBV coinfection in people with HIV.
Hepatitis B Surface Antigen
BiomarkerRelated News
GSK's Bepirovirsen Achieves 19% Functional Cure Rate in Phase III Hepatitis B Trials
GSK's Phase III B-Well trials show bepirovirsen achieved 19% functional cure in chronic hepatitis B, rising to 26% in patients with lower viral activity, versus 0% for placebo. Regulatory decisions are expected in Q3 2026.